Boehringer Ingelheim Pty

Company snapshot

Boehringer Ingelheim Pty is a pharma organization headquartered in North Ryde, AU. NovaPharmaNews links 0 clinical program(s), 8 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• 8 approved product(s) across US/EU regulatory metadata.
• 2 US patent(s) indexed to this assignee profile.
• 1 patent(s) expiring within 24 months — LOE risk moderate.

Public regulatory, clinical, patent, and corporate records for Boehringer Ingelheim Pty. Not investment advice.

• approval Jun 11, 2026

  CHMP backs nerandomilast for IPF and PPF in EU

Recent activity

Latest pipeline, patent, and corporate events for Boehringer Ingelheim Pty.

1. Dec 1, 2011 Patent grant

   VACCINE STRAINS OF BRACHYSPIRA HYODYSENTERIAE

2. Feb 14, 2008 Patent grant

   Genes and proteins of Brachyspira hyodysenteriae and uses thereof

View all clinical trial activity →

• What is Boehringer Ingelheim Pty?

  Boehringer Ingelheim Pty is a pharma organization headquartered in North Ryde, AU. NovaPharmaNews links 0 clinical program(s), 8 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• Is Boehringer Ingelheim Pty publicly traded?

  Boehringer Ingelheim Pty appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Boehringer Ingelheim Pty develop or market?

  We link 8 drug profile(s) where Boehringer Ingelheim Pty is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/boehringer-ingelheim#company-drugs.

• What are the latest developments for Boehringer Ingelheim Pty?

  Browse related news and pipeline sections on this page for coverage and ClinicalTrials.gov-linked program updates.

• What therapeutic areas does Boehringer Ingelheim Pty focus on?

  No specific therapeutic focus areas are currently identified for Boehringer Ingelheim Pty in our database.